Lexeo Therapeutics Inc’s recently made public that its Director Richard Nolan Townsend acquired Company’s shares for reported $20600.0 on Dec 10 ’24. In the deal valued at $8.24 per share,2,500 shares were bought.
Then, CHOLMONDELEY PAULA H bought 15,000 shares, generating $104,852 in total proceeds. Upon buying the shares at $6.99, the Director now owns 30,627 shares.
Before that, Townsend Richard Nolan sold 2,500 shares. Lexeo Therapeutics Inc shares valued at $19,557 were divested by the Chief Executive Officer at a price of $7.82 per share. As a result of the transaction, Townsend Richard Nolan now holds 120,695 shares, worth roughly $1.01 million.
Robert W. Baird initiated its Lexeo Therapeutics Inc [LXEO] rating to an Outperform in a research note published on June 13, 2024; the price target was $28. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in early June with a ‘”a Buy”‘ rating. Stifel began covering LXEO with “Buy” recommendation on November 28, 2023. RBC Capital Mkts started covering the stock on November 28, 2023. It rated LXEO as “an Outperform”.
Price Performance Review of LXEO
On Tuesday, Lexeo Therapeutics Inc [NASDAQ:LXEO] saw its stock jump 0.84% to $8.36. Over the last five days, the stock has gained 13.74%. Lexeo Therapeutics Inc shares have fallen nearly -37.70% since the year began. Nevertheless, the stocks have fallen -27.87% over the past one year. While a 52-week high of $22.33 was reached on 01/18/24, a 52-week low of $5.77 was recorded on 11/20/24. SMA at 50 days reached $8.21, while 200 days put it at $12.18.
Levels Of Support And Resistance For LXEO Stock
The 24-hour chart illustrates a support level at 8.03, which if violated will result in even more drops to 7.70. On the upside, there is a resistance level at 8.62. A further resistance level may holdings at 8.88. The Relative Strength Index (RSI) on the 14-day chart is 55.95, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.72, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 12.79%. Stochastics %K at 78.23% indicates the stock is a holding.
How much short interest is there in Lexeo Therapeutics Inc?
A steep rise in short interest was recorded in Lexeo Therapeutics Inc stocks on 2024-10-31, growing by 0.12 million shares to a total of 2.19 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 2.07 million shares. There was a rise of 5.51%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on November 28, 2023 when Leerink Partners began covering the stock and recommended ‘”an Outperform”‘ rating along with a $19 price target.
